S100A9 and adult-onset Still disease: Stimulation of PBMCs from AOSD patients and HCs in vitro revealed that S100A9 was an inducer of IL-1β secretion, with levels comparable to those observed with lipopolysaccharide (LPS) (Figure 3A).